Chief Executive Officer

Paul van de Wiel

Paul, CEO and co-founder, is a cell and molecular biologist with a PhD in cancer research. He is a seasoned executive with broad international experience in R&D and business management of molecular diagnostics at Organon Teknika, bioMérieux and Philips.

Paul has a passion for developing and commercializing breakthrough molecular diagnostics that contribute to improved, personalized treatment of major diseases like cancer and infectious diseases. Previously, he led the team at Organon Teknika/bioMérieux that pioneered in molecular diagnostics and developed the first real-time HIV RNA viral load test, which has been used globally for management of AIDS patients.